NCT07062055 2026-04-01BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or OligometastasesShandong Cancer Hospital and InstitutePhase 2 Recruiting54 enrolled